HEXIS R&D and production departments have developed the PRZ150 cover fitted with PURE ZONE technology. Healthcare managers, concerned about the health of their workers and patients, asked the founder of HEXIS Group, Michel Mateu, to explore the feasibility of manufacturing a product that would protect them during their interventions. As an answer, the group comes up with the PRZ150 product in the form of a flexible and transparent sheet of 1500 x 1500mm. Antimicrobial agents based on silver ions are thoroughly mixed into a solution developed by the R&D department and then coated in multi-layers homogeneously on an appropriate liner. This complex is polymerised to 200°C. PRZ150 is the result of this process, providing a great flexibility, a high transparency and an effective protection against nosocomial diseases.
PURE ZONE technology is active on the following bacterial strains: Staphylococcus aureus; Methicillin-resistant Staphylococcus aureus (MRSA); Salmonella (Salmonella enterica); Listeria (Listeria monocytogenes); Escherichia coli and Pseudomonas aeruginosa. During the patient’s treatment, this necessary primary defence protects both patient and carer by way of a transparent cover, allowing the various procedures to be performed with precision due to the PRZ150’s high transparency. This cover is used in obstetricsand can be used in other hospital departments.
